Indian Female Infertility Diagnosis And Treatment Market

Indian Female Infertility Diagnosis And Treatment Market Size, Share & Trends Analysis Report, By Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others (Laparoscopy)), By End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers), and Forecast, 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2022 | Report Code: OMR2020560 | Category : Medical Devices | Delivery Format: /

Indian female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 5.4% during the forecast period. The growth of the market is owing to the rising population, growth in healthcare infrastructure and so on. Increasing healthcare infrastructure is estimated to be one of the major factors to drive the growth of the female infertility diagnosis-treatment market. Over the past few years, considerable growth in the healthcare sector in India has been witnessed. 

Rising disposable incomes and easier access to high-quality healthcare facilities and increasing awareness towards health and personal hygiene are estimated to be the major factors that are boosting this market growth. Further, increasing medical tourism in India due to the presence of high-class healthcare facilities and low cost of treatment is again contributing significantly towards the growth of the market. The presence of quality hospitals that are offering this treatment facility along with available skilled medical professionals in India is anticipated to promote the market growth within the country.

Indian female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

Some of the major players operating in Indian female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in Indian market.

Research Methodology

The market study of Indian female infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for existing companies and new entrants into the market, potential investors and venture capitalists, government organizations, and various end-user industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions. 

Market Segmentation:

  1. Indian Female Infertility Diagnosis And Treatment  Market Research and Analysis by Diagnosis
  2. Indian Female Infertility Diagnosis And Treatment  Market Research and Analysis by Treatment
  3. Indian Female Infertility Diagnosis And Treatment  Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of Indian female infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting Indian female infertility diagnosis and treatment market.
  • Insights about market determinants which are stimulating Indian female infertility diagnosis and treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools 

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight& Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Indian Female Infertility Diagnosis And Treatment Market by Diagnosis

5.1.1. Ovulation Testing 

5.1.2. Hysterosalpingography (HSG) 

5.1.3. Hysteroscopy

5.1.4. Imaging Testing

5.1.5. Ovarian Reserve Testing

5.1.6. Hormonal Level Testing

5.1.7. Genetic Testing

5.1.8. Others (Laparoscopy)

5.2. Indian Female Infertility Diagnosis And Treatment Market by Treatment

5.2.1. Drugs 

5.2.2. Surgery

5.2.3. Intrauterine Insemination (IUI)

5.2.4. Assisted Reproductive Technology (ART)

5.3. Indian Female Infertility Diagnosis And Treatment Market by End-User

5.3.1. Hospitals and Clinics

5.3.2. Homecare

5.3.3. Pathology and Diagnostic Centers

6. Company Profiles

6.1. Abbott Laboratories, Inc.

6.2. Bayer AG

6.3. Bristol-Myers Squibb Co.

6.4. Cadila Pharmaceuticals Ltd.

6.5. Centogene AG

6.6. Cipla Ltd.

6.7. Cook Medical, Inc.

6.8. Cordex Pharma, Inc.

6.9. Eli Lilly and Co.

6.10. Endo Pharmaceuticals, Inc.

6.11. GlaxoSmithKline PLC

6.12. Intas Pharmaceuticals Ltd.

1. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)

2. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

3. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)



1. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2018 VS 2025 (%)

2. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)

3. INDIAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER, 2018 VS 2025 (%)